|
5 facts to know about the new asthma drug
ModernMedicine FDA recently approved reslizumab (Cinqair, Teva Pharmaceuticals), an injectable used with other asthma medicines for the maintenance treatment of severe asthma. Cinqair is approved for patients who have a history of severe asthma attacks … |
View full post on asthma – Google News